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Abstract A novel human nucleotide sugar transporter (NST)
which transports both UDP-glucuronic acid (UDP-GlcA) and
UDP-N-acetylgalactosamine (UDP-GalNAc) has been identi-
fied, cloned and characterized. The strategy for the identification
of the novel NST involved a search of the expressed sequence
tags database for genes related to the human UDP-galactose
transporter-related isozyme 1, followed by heterologous expres-
sion of a candidate gene (hUGTrel7) in Saccharomyces
cerevisiae and biochemical analyses. Significantly more UDP-
GlcA and UDP-GalNAc were translocated from the reaction
medium into the lumen of microsomes prepared from the
hUGTrel7-expressing yeast cells than into the control micro-
somes from cells not expressing hUGTrel7. The possibility that
this transporter participates in glucuronidation and/or chondroi-
tin sulfate biosynthesis is discussed. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Cellular glycoconjugates, including glycoproteins, glycolip-
ids and proteoglycans, are glycosylated in various ways in the
endoplasmic reticulum (ER) and the Golgi compartment. The
catalytic center of most glycosyltransferases involved in these
glycosylation processes faces the lumen of these organelles.
Therefore, a variety of nucleotide sugars, the monosaccharide
donor in oligo/polysaccharide chain elongation, have to be
transported from the cytosol into the lumen of the ER and
the Golgi apparatus by speci¢c transporters [1,2].
Analysis of such transporters that contribute to glycocon-
jugate biosynthesis in mammalian cells has led to the cloning
and characterization at the molecular level of UDP-galactose
(UDP-Gal) [3], CMP-sialic acid (CMP-Sia) [4^6] and UDP-N-
acetylglucosamine (UDP-GlcNAc) transporter cDNAs [7,8],
including UDP-Gal transporter isozyme cDNAs [9]. These
transporters are localized in the Golgi membrane, and provide
substrates utilized in the synthesis of Asn-linked oligosaccha-
rides and glycolipids. In UDP-Gal transporter-de¢cient mouse
Had-1 cells, glycosylation of glycoproteins and glycolipids is
severely impaired [10].
In this report, we describe the isolation of a cDNA whose
existence came to our notice through a search of the expressed
sequence tags database (dbEST) for genes related to the hu-
man UDP-Gal transporter-related isozyme 1 [9]. Heterolo-
gous expression of the open reading frame (ORF) of this
cDNA in the yeast Saccharomyces cerevisiae revealed that it
encodes a novel transporter that translocates both UDP-glu-
curonic acid (UDP-GlcA) and UDP-N-acetylgalactosamine
(UDP-GalNAc) from the cytosol into microsomal membrane
vesicles. Transporters that act on UDP-GlcA and UDP-Gal-
NAc, which are responsible for delivering substrates utilized
in biologically important reactions such as glucuronidation
and the synthesis of the glycosaminoglycan moiety of chon-
droitin sulfate, have not previously been cloned. Identi¢cation
of the nucleotide sugar transporters (NSTs) involved in these
biosynthetic processes would greatly help in elucidating the
mechanisms and regulation of these processes. The gene prod-
uct was expressed in the ER in mammalian cells. Based on the
substrate speci¢city and the subcellular localization, the pos-
sibility that this transporter participates in glucuronidation
and/or chondroitin sulfate biosynthesis is discussed.
2. Materials and methods
2.1. Materials
The radioactive nucleotide sugars and 3P-phosphoadenosine 5P-
phosphosulfate (PAPS) were purchased from American Radiolabeled
Chemicals, except that UDP-[4,5-3H]Gal was purchased from NEN
Life Science Products.
2.2. Yeast strain, transformation and culture
S. cerevisiae strain YPH500 (MATK ura3-52 lys2-801 ade2-101 trp1-
v63 his3-v200 leu2-v1) was used in the expression study. Yeast trans-
formation was performed using the lithium acetate method as de-
scribed previously [11]. Transformants were selected on a selective
medium containing 0.67% (w/v) Bacto-yeast nitrogen base without
amino acids, 2% glucose (YNBD), and auxotrophic supplements ex-
cept uracil. For preparation of membrane vesicles, the transformants
were grown in liquid selective medium until they reached a density of
about 0.8A600. Cupric sulfate was then added to the culture at a ¢nal
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concentration of 0.5 mM. The cells were further cultured for 2 h, and
then harvested.
2.3. Preparation of yeast membrane vesicles
Membrane vesicles were prepared essentially as previously described
[8]. Cells were washed with ice-cold 10 mM NaN3 and converted into
spheroplasts in a spheroplast solution containing 1.4 M sorbitol, 50
mM potassium phosphate (pH 7.5), 10 mM NaN3, 0.25% (v/v) 2-
mercaptoethanol, and 2 mg of zymolyase-100T (Seikagaku, Tokyo)
per g of cells, and incubated at 37‡C for 20 min. The spheroplasts
were pelleted, resuspended in ¢ve volumes of lysis bu¡er containing
0.8 M sorbitol, 10 mM HEPES^Tris (pH 7.4), 1 mM EDTA and a
protease-inhibitor cocktail (Complete, EDTA-free, Roche Diagnos-
tics), and homogenized using a Te£on homogenizer. The lysate was
centrifuged at 1500Ug for 10 min to remove unlysed cells and debris.
The supernatant was centrifuged at 10 000Ug for 10 min to yield a
pellet of membrane vesicles, P10, and the supernatant, S10. The S10
was then centrifuged at 100 000Ug for 60 min to yield a pellet of
membrane vesicles, P100, and the supernatant, S100. The P10 and
P100 fractions were resuspended in the lysis bu¡er.
2.4. Transport assay
The transport assay was performed essentially as previously de-
scribed [12]. Brie£y, the transport reaction mixture (100 Wl) used in
assays contained yeast membrane vesicles (usually 50 Wg of protein),
1 WM radiolabeled substrate, 0.8 M sorbitol, 10 mM Tris^HCl (pH 7.0),
Fig. 1. Cloning of the hUGTrel7 (human UDP-GlcA/UDP-GalNAc dual transporter) cDNA. A: The nucleotide sequence and the deduced
amino acid sequence of hUGTrel7. The DDBJ/EMBL/GenBank accession number of the nucleotide sequence is AB044343. B: Northern blot
analysis. (a) Each membrane (Clontech human multiple tissue Northern blot) was hybridized with a radiolabeled cDNA fragment encoding the
entire ORF, which was ampli¢ed by PCR from clone 1989970 as described [8]. (b) Hybridization with human L-actin cDNA (Clontech). C:
FISH was performed using lymphocytes isolated from human blood and a 1.3-kb cDNA fragment from clone 1989970 as described before [8].
(a) The arrow indicates the positive signal. (b) Summary of superimposition on DAPI banding images. FISH signals and the DAPI banding
patterns were recorded separately by making photomicrographs, and the chromosomal location of the gene was determined by superimposing
FISH signals with DAPI-banded chromosomes.
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2 mM MgCl2 and 0.5 mM dimercaptopropanol. The reaction mixture
was incubated at 30‡C. The reaction was started by addition of mem-
brane vesicles, and terminated at the appropriate time by an 11-fold
dilution with ice-cold stop bu¡er containing 0.8 M sorbitol, 10 mM
Tris^HCl (pH 7.0), 2 mM MgCl2 and 1 WM non-radiolabeled sub-
strate. The entire reaction mixture was passed through a nitrocellulose
¢lter (Millipore). The ¢lter was washed three times with 1 ml of the
ice-cold stop bu¡er, dried, and then the radioactivity trapped on the
¢lter was determined.
2.5. Immunoblotting
Immunoblotting was carried out as described previously [8]. The
HA-tagged proteins were detected with rat anti-HA monoclonal anti-
body 3F10 (Roche Diagnostics).
2.6. Immuno£uorescence
The CHO-K1 cells were transfected with an appropriate expression
vector using LipofectAMINE reagent (Life Technologies), following
the manufacturer’s instructions. 24 h after transfection, the cells were
transferred onto a Lab-Tek eight-well chamber glass slide (Nalge
Nunc International, Naperville, IL, USA) and grown for another 24
h. Then the cells were ¢xed with 3.7% formaldehyde and permeabi-
lized with 0.1% Triton X-100. The permeabilized cells were stained
with rat anti-HA mAb 3F10 followed by £uorescein isothiocyanate-
conjugated anti-rat IgG and with either a rabbit polyclonal antibody
against K-mannosidase II followed by anti-rabbit IgG-Alexa 546, or a
rabbit polyclonal antibody against ERp57 followed by anti-rabbit
IgG-Alexa 546. Fluorescence labeling was visualized under a laser
scanning confocal microscope (Carl Zeiss LSM510). Antibodies
Fig. 1 (continued).
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against K-mannosidase II and ERp57 were kindly provided by Dr. K.
Moremen (University of Georgia, Athens, GA, USA) and by Dr. H.
Taira (Iwate University, Morioka, Japan), respectively.
3. Results
3.1. Isolation of hUGTrel7 cDNA
We previously identi¢ed and characterized several genes
closely related to UDP-Gal transporter (UGTrel genes) such
as human CMP-Sia transporter [6] and human UDP-GlcNAc
transporter [8], through a search of the dbEST. This approach
was expanded to identify additional, rather distantly related
genes. In this study, we have searched the dbEST for sequen-
ces similar to the primary structure of human UGT-related
isozyme 1 (hUGTrel1) [9], and found that IMAGE cDNA
clone 1989970 encoded a protein that has signi¢cant similarity
with the hUGTrel1 amino acid sequence. Analysis of the nu-
cleic acid sequence of clone 1989970 revealed that it contains
an ORF, which encodes a protein with 355 amino acid resi-
dues, as shown in Fig. 1A. We tentatively named this gene
human UGTrel7. A database search revealed that clone
1989970 encodes the entire ORF for KIAA0260 protein
with unknown function which was reported by Nagase et al.
[13]. Expression of hUGTrel7 was ubiquitous and the mRNA
was detected as a single major band 7.0 kb in length in North-
ern blot analysis (Fig. 1B). Fluorescence in situ hybridization
(FISH) analysis clearly mapped the hUGTrel7 gene to chro-
mosome 1, p31^p32 (Fig. 1C).
3.2. Subcellular localization of hUGTrel7
hUGTrel7 showed signi¢cant similarity with hUGTrel1, a
member of the nucleotide sugar transporter subfamily, which
is distantly related to the Golgi UDP-Gal transporter [9]. We
therefore assumed that hUGTrel7 would also be a transporter
protein residing in organellar membranes, and investigated the
subcellular localization of hUGTrel7. We ¢rst tried to deter-
mine the intracellular distribution of the endogenously ex-
pressed hUGTrel7 protein using antibodies against the C-ter-
minal segment of the protein, but it was unsuccessful. The
amount of the endogenous hUGTrel7 protein may be too
small to be detected clearly by this method. The DNA se-
quence encoding hUGTrel7 tagged with an HA epitope at
the C-terminus was then introduced into the mammalian ex-
pression vector pMKIT-neo. The construct was transiently
expressed in CHO-K1 cells. The cells were doubly immuno-
stained with anti-HA monoclonal antibody and antiserum to
either K-mannosidase II or ERp57, marker proteins for Golgi
apparatus or endoplasmic reticulum, respectively. The distri-
bution of HA-tagged hUGTrel7 was co-localized with that of
ERp57, while it was not co-localized with that of K-mannosi-
dase II (Fig. 2). These data indicate that hUGTrel7 is located
in the endoplasmic reticulum in mammalian cells. It should be
Fig. 2. Subcellular localization of the hUGTrel7 protein. CHO-K1 cells were transfected with pMKIT-neo-hUGTrel7cHA. Forty-eight hours
after transfection, cells were ¢xed and permeabilized with 0.1% Triton X-100. Analysis by indirect immuno£uorescence was performed using
rabbit anti-ERp57 serum (a), rabbit anti-K-mannosidase II serum (d), and anti-HA rat mAb 3F10 (b, e). The £uorescence images (a) and (b),
and (d) and (e), are merged to yield (c) and (f), respectively.
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noted that C-terminally added HA tags did not disturb the
Golgi localization of nucleotide sugar transporters such as
CMP-Sia [6] and UDP-GlcNAc [8] transporters.
3.3. Expression of hUGTrel7 in the yeast S. cerevisiae
To test the nucleotide sugar transport activity of hUGTrel7,
we utilized a heterologous expression system of hUGTrel7 in
S. cerevisiae. We showed previously that nucleotide sugar
transporters were expressed in active form in S. cerevisiae
[8,12] and that yeast microsomes have only very low intrinsic
nucleotide sugar transporting activity except for a potent
GDP-mannose transporting activity.
The DNA sequence encoding hUGTrel7 tagged with an HA
epitope at the C-terminus was introduced into the pYEX-BX
vector. The plasmids with/without the hUGTrel7 cDNA insert
were transfected into S. cerevisiae YPH500. The membrane
fractions (P10 and P100) and the soluble fraction (S100)
were prepared from the transformed cells grown in YNBD
medium after induction with 0.5 mM CuSO4. Fig. 3 shows
an immunoblot of these fractions probed with anti-HA anti-
body. The P10 and P100 fractions from the hUGTrel7 trans-
formant contained a 37-kDa HA-tagged protein, whose ap-
parent molecular mass is consistent with the one predicted for
HA-tagged hUGTrel7 (40 kDa). This 37-kDa protein was not
detected in any fraction from cells transfected with vector
alone. These data indicate that the hUGTrel7 was heterolo-
gously expressed in S. cerevisiae intracellular membranes.
3.4. Identi¢cation of hUGTrel7 as a UDP-GlcA/UDP-GalNAc
transporter
The uptake of eight nucleotide sugars and PAPS by P10
membrane vesicles expressing hUGTrel7 was examined using
a ¢ltration method (Fig. 4). At least ¢ve times more UDP-
GlcA and UDP-GalNAc was taken up by membrane vesicles
from hUGTrel7-expressing cells than by control membrane
vesicles from cells not expressing hUGTrel7. Considerably
more UDP-GlcNAc was also incorporated into membrane
vesicles expressing hUGTrel7 than into those without hUG-
Trel7 protein. However, we cannot decide at present whether
UDP-GlcNAc serves as a substrate for hUGTrel7 protein or
not, because of lower but signi¢cant uptake of UDP-GlcNAc
by control membrane vesicles not expressing hUGTrel7 pro-
tein. The less than two-fold di¡erence in incorporation of nu-
cleotide sugar between hUGTrel7-expressing and non-express-
ing membranes is not large enough to permit a de¢nitive
conclusion. We also cannot exclude the possibility that hUG-
Trel7 transports UDP-Glc and GDP-Man. The endogenous
levels of transport of these nucleotide sugars were rather high
in S. cerevisiae, and might have obscured the transport of
these nucleotide sugars by hUGTrel7. Puri¢cation and recon-
stitution of the hUGTrel7 protein will be required for con-
clusive determination of its substrate speci¢city spectrum.
The time course of uptake of UDP-GlcA and UDP-Gal-
NAc by membrane vesicles with or without hUGTrel7 was
also studied (Fig. 5). In membrane vesicles from hUGTrel7-
expressing cells, uptake of the nucleotide sugar initially pro-
ceeded rapidly for about 1 min and then proceeded slowly for
up to 30 min. On the other hand, the uptake of UDP-GlcA
and UDP-GalNAc by the membrane vesicles from vector con-
trol cells only exhibited the slow phase throughout the 30 min.
These data further con¢rmed that the hUGTrel7 protein was
involved in the uptake of UDP-GlcA and UDP-GalNAc by
membrane vesicles.
To determine whether the uptake in fact represented entry
of UDP-GlcA and UDP-GalNAc into the lumen of the
vesicles, and not simple binding to the hUGTrel7 protein,
we measured the nucleotide sugar incorporation with mem-
brane vesicles (P10) permeabilized by treatment with Staphy-
lococcus aureus K-toxin. As shown in Fig. 5, permeabilized
vesicles were unable to accumulate the nucleotide sugars.
These data indicate that uptake of UDP-GlcA and UDP-Gal-
NAc represents the net transport of the substrates into the
lumen of the vesicles. Based on these results, we concluded
that hUGTrel7 is a UDP-GlcA and UDP-GalNAc transport-
er.
Fig. 3. Expression of the hUGTrel7 protein. P10 (lanes 1, 4), P100
(lanes 2, 5) and S100 (lanes 3, 6) fractions were prepared from yeast
carrying the expression vector pYEX-BX with (lanes 1, 2, 3) or
without (lanes 4, 5, 6) hUGTrel7cHA. An equivalent amount of
each fraction in terms of cell equivalents was analyzed by Western
blotting with anti-HA mAb 3F10. The arrowhead indicates hUG-
Trel7cHA.
Fig. 4. Substrate speci¢city of UGTrel7. Membrane vesicles (10 Wg
of protein for GDP-mannose uptake, 50 Wg of protein for the
others) from hUGTrel7-expressing S. cerevisiae cells (black bars) or
cells not expressing hUGTrel7 (white bars) were incubated in 100 Wl
of the transport reaction mixture containing 1 WM radiolabeled sub-
strate at 30‡C for 1 min. The uptake of each substrate by the mem-
brane vesicles was measured by the ¢ltration method described in
Section 2. Values are mean þ S.E.M. from duplicate experiments.
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4. Discussion
The data presented here demonstrate that hUGTrel7 trans-
ports at least two kinds of nucleotide sugars, namely UDP-
GlcA and UDP-GalNAc. This is the ¢rst NST in higher eu-
karyotes that can transport more than one nucleotide sugar.
Recently, Puglielli et al. [14] identi¢ed a UDP-GalNAc trans-
porter in rat liver Golgi membranes, and puri¢ed it from the
membranes. It is likely that hUGTrel7 is distinct from this
transporter, since the transporter from rat liver lacks the
UDP-GlcA transport activity. This leads to the new concept
that one nucleotide sugar species may be transported by var-
ious kinds of transporter molecules. Attempts to clarify the
di¡erences in transport activities and in physiological roles
between the two UDP-GalNAc transporters would contribute
much to the understanding of possible regulatory roles of
nucleotide sugar transporters in cellular glycosylation systems.
Immuno£uorescence study demonstrated that HA-tagged
hUGTrel7 protein was localized in the ER when HA-tagged
hUGTrel7 cDNA was transiently expressed in CHO cells,
although we cannot rule out the possibility that the distribu-
tion might somehow be perturbed due to its overexpression. It
is therefore likely that hUGTrel7 represents the UDP-GlcA
transporter whose occurrence in the ER has long been recog-
nized [15,16] and that hUGTrel7 is involved in supplying the
substrate nucleotide sugar for glucuronidation, which occurs
within the ER lumen [17,18]. On the other hand, the physio-
logical signi¢cance of UDP-GalNAc transport activity of
hUGTrel7 remains obscure, since UDP-GalNAc transferase
activity has so far been detected in the Golgi apparatus but
not in the ER. However, earlier works demonstrated that
UDP-GalNAc as well as UDP-GlcA was translocated into
ER-derived membrane vesicles [15,16,19]. More recently, it
was shown that on relocation of chimeric GalNAc transfer-
ases to the ER, GalNAc was added to an ER-retained form of
CD8 (CD8/E19), suggesting that all components, including
UDP-GalNAc, necessary for initiation of O-glycosylation
are present in the ER except for GalNAc transferases [20].
In view of these observations, hUGTrel7 is a good candidate
for the so far unidenti¢ed UDP-GalNAc transporter in the
ER, although its physiological roles remain to be determined.
One possibility is that UDP-GalNAc plays regulatory roles by
a¡ecting UDP-GlcA uptake into the ER. A regulatory e¡ect
of UDP-GlcNAc on UDP-GlcA transport activity in the ER
was suggested by Bossuyt and Blanckaert [21]. By analogy,
UDP-GalNAc in the cytosol may compete with UDP-GlcA
by acting as a cis-inhibitor, and/or UDP-GalNAc accumu-
lated in the ER lumen may serve as a trans-stimulator for
uptake of UDP-GlcA.
The possible involvement of this dually speci¢c transporter
in chondroitin sulfate biosynthesis is an intriguing but still
uncon¢rmed possibility. Chondroitin sulfate synthesis takes
place in the Golgi lumen [22]. The UDP-GlcA/UDP-GalNAc
transporter (UGTrel7) is expressed in the ER membrane, and
may seem unrelated to chondroitin sulfate biosynthesis. As
judged by the observed intracellular localization, UDP-Gal-
NAc-speci¢c transporter isolated from rat liver Golgi may be
responsible for this process. It should be noted, however, that
UGTrel7 can alone provide both nucleotide sugars required
for chondroitin sulfate biosynthesis, and its substrate speci¢c-
ity is reminiscent of the dually speci¢c glycosyltransferase in-
volved in chondroitin sulfate biosynthesis, L-N-acetylgalacto-
saminyltransferase II/L-glucuronyltransferase II, which was
recently puri¢ed by Tsuchida et al. [23]. According to a pro-
posed model [24], sorting of Golgi-resident proteins to their
proper destination may be a¡ected and determined by homo-
and/or hetero-oligomer formation among partner membrane
proteins. If this is the case for the sorting of the UGTrel7
transporter, then the intracellular distribution obtained under
conditions of overexpression directed by a strong promoter
may not re£ect its localization under physiological conditions
due to a shortage of its partner, possibly the dually speci¢c
GalNAc/GlcA transferase. It is tempting to speculate that
dually speci¢c nucleotide sugar transporter and glycosyltrans-
ferase behave in concert in chondroitin sulfate biosynthesis,
although at present we do not have evidence supporting this
speculation. One direct approach to these issues would be a
knock-out analysis using mice, fruit £ies or nematodes.
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